LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer

Credit: Baylor College of Medicine

Loss of one copy of the DNA ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *